# Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

> **NCT03680794** · NA · RECRUITING · sponsor: **CHU de Reims** · enrollment: 120 (estimated)

## Conditions studied

- Diabetic Retinopathy
- Retinal Vein Occlusion

## Interventions

- **OTHER:** sampling of ophthalmic liquid

## Key facts

- **NCT ID:** NCT03680794
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-27
- **Primary completion:** 2027-12-27
- **Final completion:** 2028-02-27
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680794, "Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03680794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*